Torrent Pharma reports robust performance in Q3 of FY26
Ahmedabad, Feb 13: Torrent Pharmaceuticals Limited today announced its financial results for the third quarter of FY 26.
Key Highlights for Q3 FY26:
Revenue at Rs. 3,303 crores, up by 18% YoY
Op. EBITDA* at Rs.1,088 crores, up by…
Read More...
Read More...